Sphingosine-1-phosphate Receptor 1 Agonist SEW2871 Alters Membrane Properties of Late-firing Somatostatin Expressing Neurons in the Central Lateral Amygdala
Overview
Pharmacology
Affiliations
Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid that mediates a wide spectrum of biological processes including apoptosis, immune response and inflammation. Here, we sought to understand how S1P signaling affects neuronal excitability in the central amygdala (CeA), which is a brain region associated with fear learning, aversive memory, and the affective dimension of pain. Because the G-protein coupled S1P receptor 1 (S1PR) has been shown to be the primary mediator of S1P signaling, we utilized S1PR agonist SEW2871 and S1PR antagonist NIBR to determine a potential role of S1PR in altering the cellular physiology of neurons in the lateral division of the CeA (CeL) that share the neuronal lineage marker somatostatin (Sst). CeL-Sst neurons play a critical role in expression of conditioned fear and pain modulation. Here we used transgenic breeding strategies to identify fluorescently labeled CeL-Sst neurons for electrophysiological recordings. Using principal component analysis, we identified two primary subtypes of Sst neurons within the CeL in both male and female mice. We denoted the two types regular-firing (type A) and late-firing (type B) CeL-Sst neurons. In response to SEW2871 application, Type A neurons exhibited increased input resistance, while type B neurons displayed a depolarized resting membrane potential and voltage threshold, increased current threshold, and decreased voltage height. NIBR application had no effect on CeL Sst neurons, indicating the absence of tonic S1P-induced S1PR. Our findings reveal subtypes of Sst neurons within the CeL that are uniquely affected by S1PR activation, which may have implications for how S1P alters supraspinal circuits.
Biltz R, Yin W, Goodman E, Wangler L, Davis A, Oliver B Brain Behav Immun Health. 2024; 43:100908.
PMID: 39720627 PMC: 11667635. DOI: 10.1016/j.bbih.2024.100908.
Role of Sphingosine-1-Phosphate Signaling Pathway in Pancreatic Diseases.
Fu F, Li W, Zheng X, Wu Y, Du D, Han C Int J Mol Sci. 2024; 25(21).
PMID: 39519028 PMC: 11545938. DOI: 10.3390/ijms252111474.
Cells and circuits for amygdala neuroplasticity in the transition to chronic pain.
Kiritoshi T, Yakhnitsa V, Singh S, Wilson T, Chaudhry S, Neugebauer B Cell Rep. 2024; 43(9):114669.
PMID: 39178115 PMC: 11473139. DOI: 10.1016/j.celrep.2024.114669.
Yakhnitsa V, Thompson J, Ponomareva O, Ji G, Kiritoshi T, Mahimainathan L Cells. 2024; 13(12.
PMID: 38920682 PMC: 11201618. DOI: 10.3390/cells13121055.
Crofton E, OBuckley T, Bohnsack J, Morrow A, Herman M J Neurosci. 2023; 43(42):7056-7068.
PMID: 37657933 PMC: 10586533. DOI: 10.1523/JNEUROSCI.0717-23.2023.